Finance

Lists
OSE:EPA
Ose Immunotherapeutics SA
2,00 €
-1,86%
(-0,038) 1D
23 қаз., 16:35:10 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
2,07 €
High
2,07 €
Low
1,98 €
Mkt. cap
47,82 млн
Avg. vol.
147,58 м.
Volume
106,69 м.
52-wk high
6,30 €
52-wk low
1,98 €
EPS
-1,69 €
Shares outstanding
23,56 млн
No. of employees
64
Open
2,07 €
High
2,07 €
Low
1,98 €
Mkt. cap
47,82 млн
Avg. vol.
147,58 м.
Volume
106,69 м.
52-wk high
6,30 €
52-wk low
1,98 €
EPS
-1,69 €
Shares outstanding
23,56 млн
No. of employees
64
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
27 минут бұрын
The S&P 500 Is At A Crossroads, That's A Buying Opportunity (SP500)
Bloomberg.com
Bloomberg.com
·
6 сағат бұрын
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Yahoo Finance
Yahoo Finance
·
5 сағат бұрын
Dow: 3 Key Takeaways for Long-Term Investors
Investor's Business Daily
Investor's Business Daily
·
1 сағат бұрын
Futures Due; It's A Doom-And-Bloom Market
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded2004 ж. 17 қар.
Headquarters-
Sector-
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2024 ж. қыр.
2024 ж. жел.
Revenue
431,00 м.
431,00 м.
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 млн
8,28 млн
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 млн
1,08 млн
Operating expense
10,22 млн
10,22 млн
Total operating expenses
10,22 млн
10,22 млн
Operating income
-9,79 млн
-9,79 млн
Other non operating income
-611,00 м.
-611,00 м.
EBT including unusual items
-10,44 млн
-10,44 млн
EBT excluding unusual items
-10,53 млн
-10,53 млн
Income tax expense
-576,50 м.
-576,50 м.
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 мың
41,00 мың
Net income
-9,86 млн
-9,86 млн
Net profit margin
-2 288,86%
-2 288,86%
Earnings per share
-
-
Interest and investment income
571,00 м.
571,00 м.
Interest expense
-707,50 м.
-707,50 м.
Net interest expenses
-136,50 м.
-136,50 м.
Depreciation and amortization charges
-
-
EBITDA
-9,74 млн
-9,74 млн
Gain or loss from assets sale
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары